NCT03283696 2020-09-10A Study of Olaratumab (LY3012207), Doxorubicin, and Ifosfamide in Participants With Advanced or Metastatic Soft Tissue SarcomaEli Lilly and CompanyPhase 1 Completed24 enrolled 21 charts